Jiangsu Recbio and Shanghai Rongsheng Collaborate on New Vaccine Development Project
Jiangsu Recbio Technology Co., Ltd. and Shanghai Rongsheng Biotech Co.,Ltd. have recently announced a strategic cooperation for a groundbreaking new adjuvant vaccine research and development project in Shanghai. The partnership aims to revolutionize the creation of adjuvant vaccines through joint efforts.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
